Carclo plc

Carclo plc, together with its subsidiaries, engages in manufacture and sale of fine tolerance injection molded plastic parts. It operates through three segments: Technical Plastics, Aerospace, and Central. The company offers fine tolerance and injection molded plastic components for use in the medical, optical, diagnostics, and electronic products. It also provides various specialist components, including control cables, specialist machined components, aerofoil blading, streamline wires, and tie rods for the commercial and military aerospace industries. The company operates in the United Kingdom, North America, the Czech Republic, China, India, and internationally. Carclo plc was incorporated in 1924 and is based in Ossett, the United Kingdom.

Carclo plc trades as CCEGF on OTC. The company is classified in Consumer Cyclical / Auto - Parts and reports in USD.

The current profile places the business in Auto - Parts. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $121.22M of revenue and $872,000 of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Carclo plc can be compared against peers such as Catena Media plc, ENM Holdings Limited, Hartford Great Health Corp., Imaflex Inc., Leatt Corporation, Meritage Hospitality Group Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $49.19M, beta of 0.68, and return on equity of -7.4%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

CCEGF currently shows total debt of $29.95M and beta of 0.68. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.carclo.co.uk

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.